News Focus
News Focus
Followers 24
Posts 3957
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Monday, 01/21/2008 1:29:31 PM

Monday, January 21, 2008 1:29:31 PM

Post# of 19309
READ ME FIRST - Patent Application Updates

1. TRANSGENICALLY PRODUCED ANTITHROMBIN III AND MUTANTS THEREOF
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=AT381260T&F=0

2. Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US2008004212&F=0

3. Methods of protein fractionation using high performance tangential flow filtration
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=CN101027080&F=0'

4. A METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1850872&F=0

5. AN ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATEMENT OF CANCER AND GLYCOSYLATION VARIANTS THEREOF
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1851244&F=0

6. METHODS AND PRODUCTS RELATED TO THE TRANSFER OF MOLECULES FROM BLOOD TO THE MAMMARY GLAND
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007124019&F=0

7. CLARIFICATION OF TRANSGENIC MILK USING DEPTH FILTRATION
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007106078&F=0

8. Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US7271312&F=0

9. ERYTHROPOIETIN ANALOG-HUMAN SERUM ALBUMIN FUSION
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=DE69933216T&F=0

10. Transgenic production of antibodies in milk
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=AU2007205719&F=0

Intellectual property - Compliments of DEW
#msg-22560060 “Milk” patent
#msg-7179529 Purification patent
#msg-18949245 IP summary from most recent 10K report
#msg-25410579 Musings on fibrinogen IP
#msg-18615705 Nuclear-transfer license from Geron
#msg-19226707 Notes on nuclear-transfer license

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today